Lineage Cell Therapeutics, Inc.
USD1.21
-0.06 (-4.35%)
CEO
Brian Culley
IPO Date
1992-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.21
Prev. Close
$1.26
Day Low
$1.19
Day High
$1.25
52W Low
$0.65
52W High
$2.09
Market Cap
$0.30B
Volume
1.67M
| 3,250,000 |
| $1.84 |
| 6 Mar 2026 | Howe Jill Ann | Chief Financial Officer | A-Award | Acquired | 1,050,000 | $1.84 |
| 6 Mar 2026 | Samuel George A. III | General Counsel and Secretary | A-Award | Acquired | 900,000 | $1.84 |
| 13 Feb 2026 | Culley Brian M | director, officer: President and CEO | M-Exempt | Disposed | 31,250 | $0.00 |
| 13 Feb 2026 | Culley Brian M | director, officer: President and CEO | M-Exempt | Acquired | 31,250 | $0.00 |
| 13 Feb 2026 | Culley Brian M | director, officer: President and CEO | F-InKind | Disposed | 12,869 | $1.80 |
| 13 Feb 2026 | Samuel George A. III | General Counsel and Secretary | M-Exempt | Acquired | 6,075 | $0.00 |
| 13 Feb 2026 | Samuel George A. III | General Counsel and Secretary | F-InKind | Disposed | 2,502 | $1.80 |
| 13 Feb 2026 | Samuel George A. III | General Counsel and Secretary | M-Exempt | Disposed | 6,075 | $0.00 |